Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy; a Placebo-controlled Trial

NCT07052799 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07052799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07052799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy; a Placebo-controlled Trial
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 3
Overall status
Recruiting
Start date
February 10, 2026
Completion date
December 31, 2031
Enrollment
2,514 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular events, myocardial infarction (mi), post polypectomy bleeding in antiplatelet patients